News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Interleukin Genetics Inc. (ILGN) Expands Research Collaboration with Alticor, Inc.



3/30/2007 12:02:14 PM

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (AMEX: ILI) reported today that it has entered into a new research agreement with Access Business Group International LLC (ABG), a subsidiary of Alticor Inc. The research agreement encompasses the development of genetic tests to guide consumers’ selection of appropriate skin care products; the further development of tests for weight management and the risk of osteoporosis, as well as the development of other tests. Under the terms of the agreement, Interleukin is eligible to receive up to $2.3 million in additional research funding during 2007.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES